The effect of alloxan diabetes on mobilization of the liver glycogen was followed in male rats given one injection of alloxan (200mg/kg). The serum glucose showed a typical triphasic curve, reaching sustained hyperglycemia 24hr after injection. The insulin levels of serum and pancreatic tissue extract remained within normal limits for the first 24hr. The marked decrease in insulin levels from both sources was recorded on the third day. The concentration of liver glycogen, however, was already markedly decreased at the end of one hr after injection, continued at the low contents up to the 12th hr, then it temporaly rose to reach a normal value after 24hr. The outer chain length of the glycogen from one to 12hr after injection was shorter than normal and was close to the phosphorylase limit dextrin. Probably the glucose liberated by the breakdown of the outer chain of the glycogen has led to an early phase hyperglycemia. After 7 days of alloxan-induced diabates, the total hepatic glycogen as well as biochemical structure became reestablished to normal. A further discussion on interaction of alloxan and glucose is given.
The response of serum glucose to the injection of alloxan shows three phases: initial hyperglycemia, interrupted by temporary hypoglycemia, which is followed by permanent hyperglycemia (Wrenshall et al., 1950) . The mechanism of initial hyperglycemia is still unknown, although it has been ascribed to a direct action of alloxan on the liver or to sympathoadrenal discharge (Goodman et al., 1958) . This experiment was designed to investigate the concentration and the outer chain length of the hepatic glycogen in a temporal relation to serum glucose. It comes to the conclusion that initial hyperglycemia is due to immediate breakdown of hepatic glycogen to glucose from the results of immediate decrease of hepatic glycogen and its characteristics being close to the phosphorylase limit dextrin (Walker and Whelan, 1960; Whelan et al., 1964) . The serum and pancreatic tissue extracted insulin levels were within low normal limits throughout the first 24hr, during which all of the three phases of blood glucose response had taken place.
Materials and Methods
Albino male rats, weighing 250-350 gm., were given alloxan monohydrate (Sigma)(200mg/kg body weight) either intramuscularly or intraperitoneally as reported previously (Tomita, 1972a) . The alloxanized rats were anesthesized with Nembutal and were sacrificed at 1, 2, 4, 7, 12, and 24hr. Control rats, which were given the same amount of Ringer solution were sacrificed at the same time. Some of the alloxanized rats were observed for relatively longer periods and were sacrificed on the third, seventh and 28th days respectively. Blood was drawn from the left ventricle and serum glucose was determined by glu- (Hodges et al., 1969) .
R esu l ts
Serum glucose showed initial hyperglycemia, reaching the maximum at 4-7hr, then intermittent hypoglycemia at the 12th hr. The permanent hyperglycemia started at the 24th hr and this pancreatic diabetes continued throughout the 28 day peroid observed in this series. Serum insulin levels did not decrease markedly during the first 24hr, but on the third day the insulin level was minimum when the complete disappearance of beta-granules of the pancreatic islet was confirmed by histochemistry and electron microscopy (Fig .   Fig. 1 1). Acid ethanol extractable insulin levels of the pancreas remained at the lower normal values during the first 24hr, then these values have been 1/10-1/14 of the normal from the third day through 28 day period.
The Table 1 shows glycogen content of alloxanized rat liver and its percentage degradation by beta-amylase and phosphorylase. Glycogen decreased immediately to 1/6 of the normal at the end of one hr after alloxan injection and this low hepatic glycogen continued up to the 12th hr. Beta-amylase degradation of glycogen was around 30%, and phosphorylase degradation was extremely low compared with the control values. At 24hr after injection, glycogen value once rose to the normal with normal outer chain length. On the third day, glycogen content again decreased markedly, showing about 1/9 of the normal with very low enzymatic degradation rates. After one week, all of the surviving rats showed normal amount of glycogen with normal outer chain length. (Table  3) . These values were consistent with the phosphorylase limit dextrin or the limit dextrin found in the Table 3 . KI-I2 absorbance of various glycogens *0 .2ml of glycogen solution (0.1-0.5mg) in distilled water was treated as mentioned in the Table 2. patients with type 3 glycogenosis (Sidbury et al., 1961) .
Disc ussion
Many studies of influence of alloxan diabetes on the glycolytic and glyconeogenic enzyme activities of the liver had been reported (Anderson and Zakin, 1970; Gold, 1970; Jakobsson and Dallner, 1968; Kraupp et al., 1967) . Most of the studies concluded glycolytic enzyme activity increased while glycogen synthetase activity decreased at least during the early stages of alloxan diabetes. These changes in enzyme activity were to be corrected to normal by treating the experimental animals with adequate amount of insulin (Haft, 1968; Gold, 1970; Kraupp et al., 1967) . Liver glycogen was reported either to decrease or to increase after alloxan injection depending on the individual experiment employed by different investigators (Jakobsson and Daller, 1968; Kraupp et al., 1967) . This experiment showed a marked decrease of hepatic glycogen content being recognized at the first hr after administration of alloxan. Followed by fluctuation in hepatic glycogen levels for a few days, hepatic glycogen content was reestablished to normal after 7 days. The liver glycogen content from human diabetes was higher than normal in the presence of hyperglycemia and hepatomegaly (Vaishnava et al., 1971) . The untreated alloxan-diabetic rats are apparently undernourished and the results presented here are not compatible with the studies of human diabetics, since the degree of long-term alloxan diabetes is extremely severe with absolute shortage of both serum and pancreatic insulin. Further study shows total number of isolated islets from alloxan diabetic rats by collagenase technique is about 1/4 of the normal, and each islet is extremely smaller than normal one (Tomita, 1972c, In Preparation) . Outer chain length determinations by both beta-amylase and phosphorylase showed the hepatic glycogen from early alloxan-induced diabetic rats to be close to the phosphorylase limit dextrin. This glycogen with short outer chains showed less than 30 percent degradation by beta-amylase and an extremely low degradation by phosphorylase (Illingworth and Cori, 1952; walker and Whelan, 1960; Whelan et al., 1964 (Tomita, 1972b) . Possibility of chemical reaction between alloxan and glucose is to be excluded from the fact that alloxan does not react with glucose and stability of alloxan does not change in high glucose solutions (Webb, 1966) .
Thus, immediate glycogenolysis is the protective action against alloxan toxicity. The failure of adequate mobilization into serum glucose, as early and much enough to interact against alloxan, can be postulated as one of the selective toxicities on the beta islet cells of the rats.
